Altman Peter's Form 4/A amendment
AmendedBioCardia, Inc. (BCDA) · filed Apr 14, 2023
- Accession no.
- 0001437749-23-010355
- Filed
- Apr 14, 2023
- Trade date
- May 13, 2022
- Filing delay
- 336 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 13, 2022
This filing lists 1 non-derivative transaction. It carries over 3 transactions from the original filing that it did not restate. Open-market purchases total $18.6K. It was filed 336 days after the trade.
This amendment restates part of 0001437749-22-012420 (filed May 13, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altman PeterCIK 0001647542 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2022 | Common Stock | AGrant or awardDisposed | −3,498 | $1.37F2 | −$4,792.26 | 348,943 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001437749-22-012420 (filed May 13, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $1.30F1 | +$1,300 | 334,143 | Direct | |
| May 12, 2022 | Common Stock | PPurchaseAcquired | +11,302 | $1.20F2 | +$13,562.4 | 345,445 | Direct | |
| May 13, 2022 | Common Stock | PPurchaseAcquired | +2,698 | $1.38F3 | +$3,723.24 | 348,143 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F1
This transaction was executed in multiple trades ranging from $1.29 to $1.30 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades ranging from $1.13 to $1.40 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades ranging from $1.32 to $1.45 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The original Form 4 filed on May 13, 2022 incorrectly reported that 2,698 shares were purchased. 3,498 shares were purchased on May 13, 2022 and are correctly reported herein.
- F2
This transaction was executed in multiple trades ranging from $1.32 to $1.45 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
The original Form 4 incorrectly reported that 348,143 shares were beneficially owned following the reported transaction. The corrected amount is reported herein.